CLINICO–PATHOGENETIC JUSTIFICATION OF THE BIORREGULATORY DRUG TRAUMEL S EFFICACY IN THE TREATMENT AND COMPLICATIONS PREVENTION AT ACUTE RESPIRATORY INFECTIONS

Authors

  • L. S. Babinets I. Horbachevsky Ternopil National Medical University
  • M. A. Guliy I. Horbachevsky Ternopil National Medical University
  • N. G. Lerman Ukrainian Academy of Bioregulatory Medicine

DOI:

https://doi.org/10.11603/1811-2471.2020.v.i3.11580

Keywords:

acute respiratory infection, influenza, bioregulatory drug, resolution of inflammation, treatment and prevention of complications, Traumel S

Abstract

Every year 4.0–4.8 million cases of acute respiratory infections (ARI) and influenza are registered in Ukraine, which makes the research topic relevant. The most rational approach to the management of patients with ARI is a preventive approach. That is why in recent years scientists and practitioners have been recommending adjuvants that increase the body᾽s resistance to infections and restore the damaged functions of organs and systems of the sick person to the increasingly well-known tactics of managing patients with ARI "Expect and observe".

The aim of the study – to learn the effectiveness of the drug Traumel S in uncomplicated acute respiratory infection in adults and children to prevent complications of the upper and lower respiratory tract of inflammatory origin.

Material and Methods. To achieve this goal, a multicenter open prospective comparative clinical trial was conducted on 300 patients (200 adults and 100 children) with a confirmed diagnosis of ARI. The duration of the study was 21 days: the course of treatment – 14 days, the observation period – 7 days. Adults (men and women aged 18–65 years) and children of both sexes (aged 1–18 years) took part in the trial.

Results and Discussion. There was a statistically significant higher efficacy of complex treatment with the inclusion the tablets Traumel S course on the relief of clinical symptoms of ARI in patients and adults (p≤0.05), as well as on the prevention of inflammatory complications (complications were only 10.0 % of patients group with Traumel S and 47.0 % – patients of the standard treatment group), which contributed to a significantly lower need for NSAIDs and antibiotics (only 15.0 % of patients in the group with Traumel S required NSAIDs and 2.0 % – antibiotics in relation to 64.0 % and 33.0 % of patients in the standard therapy group).

Conclusions. The effectiveness of treatment with the inclusion of Traumel S was higher than standard treatment: a decrease of 12.5 % ​​in leukocytes, 11.8 % – rod-shaped leukocytes, 11.4 % – segments, 6.6 % – ESR, 81.5 % – C-reactive protein, 9.6 % – an increase in lymphocytes (p≤0.05).

The higher efficiency of the medical complex strengthened by a course of Traumel S, on all pathologically changed parameters of the general analysis of blood of patients of children᾽s age is proved: decrease by 9.5 % – indicator of leukocytes, by 11.8 % – rod–shaped leukocytes, by 6.7 % – segments, 8.8 % – eosinophils, 23.9 % – ESR, 67.7 % – C–reactive protein (p≤0.05).

References

Mostovoho, Yu.M. (2019). Suchasni klasyfikatsii ta standarty likuvannia zakhvoriuvan vnutrishnikh orhaniv. Nevidkladni stany v terapii. Analizy: normatyvni pokaznyky, traktuvannia zmin [Modern classifications and standards of treatment of diseases of internal organs. Emergencies in therapy. Analyzes: normative indicators, interpretation of changes]. Kyiv: Tsentr DZK [in Ukrainian].

Kočevar-Guček, N., & Homar, V. (2012). Akutne okužbe dihal (Acute Respiratory Infections). Družinska medicina (Family Medicine) in I. Švab, D. Rotar-Pavlič. Ljubljana: Združenje zdravnikov družinske medicine (Association of Family Physicians).

Katić, M., & Švab, I. (2017). Family medicine. Izdavač: Medicinska naklada, Zagreb, 512, 53-68.

https://phc.org.ua/news/zakhvoryuvanist–na–grip–ta–grvi–v–ukraini–pidsumki–epidemichnogo–sezonu–20182019.

Kramaryev, S.O. (2010). Epidemiia hrypu v Ukraini [The flu epidemic in Ukraine]. Z turbotoiu pro dytynu: nauk.-prakt. zhurn. dlia pediatriv – With care for the child: scientific-practical. magazine for pediatricians, 1, 9-12 [in Ukrainian].

(2018). WHO Library Cataloguing-in-Publication Data, The world health report 2018: primary health care now more than ever. WHO.

WHO: Influenza (Seasonal). WHO. Retrieved from: http://www.who.int/mediacentre/factsheets/fs211/en/.

https://www.cdc.gov/flu/about/burden/preliminary–in–season–estimates.htm.

Antypkin, Yu.H. (2008). Aktualni pytannia vaktsynatsii ditei [Current issues of vaccination of children]. Perynatolohiia i pediatriia – Perinatology and Pediatrics, 4, 11-12 [in Ukrainian].

Newburg, D.N., & Walker, W.A. (2004). Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr. Res.,61, 3, 2-8.

Babinets, L.S., Borovyk, I.O., & Andriyuk, L.V. (2019). Zakhvoriuvannia orhaniv dykhannia v simeinii medytsyni [Respiratory diseases in family medicine]. Kyiv: VSV “Medytsyna” [in Ukrainian].

Mironenko, A.P., & Mukhopad, V.O. (2001). Stratehii ta stadii kontroliu hrypu [Strategies and stages of influenza control]. Infektsiini khvoroby – Infectious Diseases, 2, 55-58 [in Ukrainian].

Babinets, L. S., & Kotsaba, Y. Y. (2019). Aktualni pytannia diahnostyky i taktyky vedennia patsiientiv z HRI v ambulatornii praktytsi ta vykladanni [Actual issues of diagnostics and management tactics of patients with acute respiratory infections in outpatient practice and teaching]. Zdobutky klinichnoi i eksperymentalnoi medytsyny – Achievements of Clinical and Experimental Medicine, 3, 6-12. Retrieved from: https://doi.org/10.11603/1811-2471.2019.v.i3.10437 [in Ukrainian]. DOI: https://doi.org/10.11603/1811-2471.2019.v.i3.10437

Laine, L. (2016). GI risk and risk factors of NSAIDs. J. Cardiovasc. Pharmacol., 47, (1), 60-66.

Leong, R.W., & Chan, F.K. (2006). Drug-induced side effects affecting the gastrointestinal tract. Expert. Opin. Drug. Saf., 5 (4), 585-592. DOI: https://doi.org/10.1517/14740338.5.4.585

Fortun, P.J., & Hawkey, C.J. (2007). Nonsteroidal antiinflammatory drugs and the small intestine. Curr. Opin. Gastroenterol., 23 (2), 134-141. DOI: https://doi.org/10.1097/MOG.0b013e328020045a

Babinets, L.S. (2019). Aktualni aspekty Yevropeiskoho klinichnoho protokolu (Khorvatiia) shchodo menedzhmentu hostroi respiratornoi infektsii v ambulatornii praktytsi i vykladanni [Actual aspects of the European clinical protocol (Croatia) on the management of acute respiratory infection in outpatient practice and teaching]. Simeina medytsyna – Family Medicine, 5, 23-25 [in Ukrainian].

National Institute for Health and Clinical Excellence (NICE). (2018). Respiratory tract infections – antibiotic prescribing. Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care (clinical guidelines). London, UK: NICE. Retrieved from: https://www.nice.org.uk/GeneralError?aspxerrorpath=/nicmedia/phf/CG69%20FullGuideline.%20pdf.

St. Laurent III, G., Seilheimer, B., Tackett, M., Zhou, J., Shtokalo, D., Vyatkin, Y., …, & McCaffrey, T.A. (2017). Deep sequencing transcriptome analysis of murine wound healing: effects of a multicomponent, multitarget natural product therapy - Tr14. Front. Mol. Biosci., 4, 57. DOI:10.3389/fmolb.2017.00057. DOI: https://doi.org/10.3389/fmolb.2017.00057

St. Laurent, G., Toma, I., Tackett, M., Zhou, J., Ri, M., Shtokalo, D., …, & Mccaffrey, T. (2018). AB0080 Differential effects of tr14 versus diclofenac on pro-resolving lipid mediators revealed by rnaseq. Ann. Rheum. Dis., 77 (2), 1237-1238. DOI: 10.1136/annrheumdis-2018-eular.3789. DOI: https://doi.org/10.1136/annrheumdis-2018-eular.3789

(2016). Efektyvnist vykorystannia Traumel S u kompleksnomu likuvanni hostroho synusytu u ditei [The effectiveness of the use of Traumel C in the complex treatment of acute sinusitis in children]. Zdorovye rebenka – Child’s Health, 4 (72), 57-62.

Smiyan, O.I., Moshchych, O.P., Bynda, T.P., & Dychko, M.M. (2016). Efektyvnist vykorystannia Traumel S u kompleksnomu likuvanni hostroho synusytu u ditei [The effectiveness of the use of Traumel C in the complex treatment of acute sinusitis in children]. Zdorovye rebenka – Child’s Health, 4 (72), 57-62 [in Ukrainian].

Babinets, L.S. (2019). Adiuvantni mozhlyvosti biorehuliatsiinoho pidkhodu do vedennia patsiientiv iz khronichnym pankreatytom [Adjuvant possibilities of bioregulatory approach to the management of patients with chronic pancreatitis]. Zdorovia Ukrainy – Health of Ukraine, 17 (462), 46-47 [in Ukrainian].

Kramaryev, S.O., Palatna, L.O., & Shamuhiya, B.K. (2006). Alternatyvni metody likuvannia ta profilaktyky hrypu ta HRVI v ditei (Metodychni rekomendatsii MOZ Ukrainy) [Alternative methods of treatment and prevention of influenza and SARS in children (Methodical recommendations of the Ministry of Health of Ukraine)]. Kyiv [in Ukrainian].

Khayne, Kh., & Shmolts, M.V. (1998). Immunologicheskaya vspomogatelnaya reaktsiya, vyzyvayemaya rastitelnymi ekstraktami, soderzhashchimisya v antigomotoksicheskikh preparatakh [Immunological auxiliary reaction caused by plant extracts contained in antihomotoxic drugs]. Biologicheskaya meditsina – Biological Medicine, 2, 9-11 [in Russian].

González de Vega, C., Speed, C., Wolfarth, B., & González, J. (2013). Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int. J. Clin. Pract., 979-989. DOI:10.1111/ijcp.12219. DOI: https://doi.org/10.1111/ijcp.12219

Vanden Bossche, L., & Vanderstraeten, G. (2015). A multi–center, double–blind, randomized, placebo–controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol. BMC Musculoskelet Disord., 16, 8. Retrieved from: https://doi.org/10.1186/s12891–015–0471–z. DOI: https://doi.org/10.1186/s12891-015-0471-z

Humenyuk, M.I., Denysov, O.S., & Feshchenko, Yu.I. (2010). Antybiotykorezystentnist mikroorhanizmiv. Stan problemy ta shliakhy vyrishennia [Antibiotic resistance of microorganisms. The state of the problem and solutions]. Ukrainskii khimioterapevtychnyi zhurnal – Ukrainian Journal of Chemotherapy, 1–2 (23), 4-10 [in Ukrainian].

Published

2020-09-29

How to Cite

Babinets, L. S., Guliy, M. A., & Lerman, N. G. (2020). CLINICO–PATHOGENETIC JUSTIFICATION OF THE BIORREGULATORY DRUG TRAUMEL S EFFICACY IN THE TREATMENT AND COMPLICATIONS PREVENTION AT ACUTE RESPIRATORY INFECTIONS. Achievements of Clinical and Experimental Medicine, (3), 32–44. https://doi.org/10.11603/1811-2471.2020.v.i3.11580

Issue

Section

Оригінальні дослідження